Brief: Silo Pharma Announces Positive Results For Novel SPC-15 Treatment
18/11/2024 13:53
Nov 18 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA ANNOUNCES POSITIVE RESULTS FOR NOVEL SPC-15
TREATMENT TARGETING STRESS-RELATED DISORDERS
* SILO PHARMA INC - SPC-15 SHOWS POTENTIAL FOR TREATING
MAJOR
DEPRESSIVE DISORDER
* SILO PHARMA INC - COMBINATION THERAPY REDUCES STRESS
BEHAVIORS
IN ANIMAL MODELS
Source text: ID:nGNX4XLQCR
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement